short bowel syndrome sbs simply short gut rare malabsorption disorder caused lack functional small primary symptom diarrhea result dehydration malnutrition weight symptoms may include bloating heartburn feeling tired lactose intolerance foulsmelling complications include anemia kidney cases due surgical removal large portion small often required due crohns disease adults necrotising enterocolitis young causes include damage small intestine means born abnormally short usually develop less ft normally ft small intestine treatment may include specific diet medications diet may include slightly salty slightly sweet liquids vitamin mineral supplements small frequent meals avoidance high fat occasionally nutrients need given intravenous line known parenteral medications used may include antibiotics antacids loperamide teduglutide growth different types surgery including intestinal transplant may help short bowel syndrome newly occurs three per million people estimated people condition united prevalence united states approximately cases per million europe approximately cases per million rate varies widely prevalence short bowel syndrome increased fold last classified rare disease european medicines outcomes depend amount bowel remaining whether small bowel remains connected large symptoms short bowel syndrome includecitation needed persons short bowel syndrome may complications caused malabsorption vitamins minerals deficiencies vitamins e k folic acid calcium magnesium iron zinc may appear anemia hyperkeratosis scaling skin easy bruising muscle spasms poor blood clotting bone paincitation needed short bowel syndrome adults children commonly caused surgery intestinal undergo intestinal resection approximately eventually develop small bowel syndrome due large resection due multiple separate intestinal surgery may done children also born abnormally short small intestine known congenital short surgical complications requiring resurgery common cause small bowel syndrome contributing cases based surgical complications include internal hernias volvuli ischemia profound length small intestine vary greatly short ft long average due variation recommended following surgery amount bowel remaining specified rather amount short bowel syndrome usually develops less meters feet small intestine left absorb sufficient nutrientscitation needed resection specific areas small bowel lead distinct symptoms short bowel syndrome resection ileum leads malabsorption vitamin bile acids fat soluble vitamins e loss distal ileum also leads loss inhibitory hormones leading gastric hypersecretion intestinal hypermotility decreases intestinal transit time leading secretory diarrhea macronutrient micronutrient vitamin mineral loss ileocecal valve leads small intestinal bacterial overgrowthsibo bacterial flora normally found large intestines migrate proximally colonize small intestines leading sibo leads malabsorption bacteria colonizing small intestine metabolize nutrients directly competing intestinal absorption nutrients bacteria colonizing small intestines sibo may also cause bile acid deconjugation leading malabsorption process called intestinal adaptation physiological changes remaining portion small intestine occur increase absorptive capacity changes usually take place changes include osteoporosis common comorbidity people short bowel syndrome parenteral nutrition estimated prevalence contributing factors osteoporosis include malnutrition vitamin deficiency due malabsorption vitamin deficiency due scarce sunlight exposure due chronic intestinal failure decreased intestinal function nutrients water electrolytes sufficiently absorbed short bowel syndrome less ft working bowel common cause intestinal symptoms short bowel syndrome usually addressed medication includecitation needed usfda approved therapy reduces frequency volume total parenteral nutrition tpn comprising nutrestore oral solution glutamine zorbtive growth hormone recombinant dna origin injection together specialized oral weeks successful phase iii patient treatment trials teduglutide shown relatively safe effective varying degrees benefits adverse effects per adequate safety evaluations prove difficult due limited sample size available study advisory panel usfda voted unanimously approve treatment sbs agent teduglutide glucagonlike analog developed nps pharmaceuticals intend market agent united states brandname teduglutide previously approved use europe marketed brand revestive antiperistaltic transverse coloplasty proposed prophylactic measure short bowel syndrome retains transverse colon function extensive colectomies promoting improved stool consistency quality life technique involves repositioning colon simulate original placement potentially averting short bowel syndromerelated complications benefiting patient surgical procedures lengthen dilated bowel include bianchi procedure bowel cut half one end sewn newer procedure called serial transverse enteroplasty step bowel cut stapled zigzag pattern heung bae kim md tom jaksic md childrens hospital boston devised step procedure early procedure lengthens bowel children sbs may allow children avoid need intestinal transplantation june kim jaksic performed step bianchi step procedures usually performed pediatric surgeons quaternary hospitals specialize small bowel surgerycitation needed resection remnant small bowel length less cm remaining large bowel length less original length associated subsequent dependence parenteral cure short bowel syndrome except transplant newborn infants survival rate parenteral nutrition approximately newborn infants less expected intestinal length year survival approximately studies suggest much mortality due complication total parenteral nutrition tpn especially chronic liver much hope vested omegaven type lipid tpn feed recent case reports suggest risk liver disease much although promising small intestine transplant mixed success rate postoperative mortality rate oneyear survival rate respectivelycitation needed httpsenwikipediaorgwikishortbowelsyndrome